Graphics


Figure EYE-1 part (i): Lifetime, last year and last month prevalence of cannabis use among 15 to 16 year old school students in 2003

Figure EYE-1 part (ii): Lifetime prevalence of cannabis use among 15 to 16 year old school students reported in the 1995, 1999 and 2003 rounds of the ESPAD survey

Figure EYE-1 part (iii): Comparison of male and female school students' lifetime prevalence (percentage) of cannabis use 40 or more times among 15 to 16 year old school students in 2003

Figure EYE-1 part (iv): Comparison of 15 to 16 and 17 to 18 year old school students' current (last month) prevalence of cannabis use in 2003

Figure EYE-1 part (v): Comparison of lifetime prevalence of cannabis use with perceived great risk (percentages), among 15 to 16 year old school students in 2003

Figure EYE-1 part (vi): Comparison of lifetime prevalence for cannabis and ecstasy use with easy availability (percentages) among 15 to 16 year old school students in 2003

Figure EYE-1 part (vii): Comparison of 1999 and 2003 (percentage) of 15 to 16 year old school students who reported that they first used cannabis 13 years or younger

Figure EYE-1 part (viii): Comparison of lifetime prevalence (percentage) of cannabis use and drinking 5 or more drinks in a row during past month among 15 to 16 year old school students in 200

Figure EYE-1 part (ix): Changes 1995 to 2003 in percentage lifetime prevalence of cannabis use among 15 to 16 year old school students

Figure EYE-2 part (i): Changes 1995-2003 in lifetime prevalence (percentage) of ecstasy use among 15 to 16 year old school students

Figure EYE-2 part (ii): Comparison of lifetime prevalence of ecstasy use with perceived great risk (percentages) among 15 to 16 year old school students

Figure EYE-2 part (iii): Comparison of last month prevalence of drinking 5 or more alcoholic drinks in a row with perceived great risk (percentages) among 15 to 16 year old school students in 2003

Figure EYE-2 part (iv): Comparison of lifetime prevalence of cocaine use with perceived great risk (percentages) among 15 to 16 year old school students in 2003

Figure EYE-2 part (v): Lifetime prevalence for use of ecstasy, LSD and other hallucinogens and magic mushrooms (percentages) among 15 to 16 year old school students in 2003

Figure EYE-2 part (vi): Lifetime prevalence for use of ecstasy and amphetamines (percentages) among 15 to 16 year old school students in 2003